ADR highlights from 2000

Curel, Pauline

Reactions Weekly (833):p 3-6, January 6, 2001.

The 2000 drug safety arena was notable for the large number of labelling changes and regulatory actions that resulted from safety concerns. Investigations into the association between antiretroviral drugs and metabolic disorders continued. After receiving a lot of bad press in previous years, the news on vaccines in 2000 was more positive.